Patents by Inventor Lauren Otsuki

Lauren Otsuki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SKIN PEEL COMPOSITIONS
    Publication number: 20240041740
    Abstract: The present invention relates to compositions for peeling of surface skin of a subject and methods of using the compositions. Such compositions and methods are useful for improving the appearance of the skin.
    Type: Application
    Filed: October 20, 2023
    Publication date: February 8, 2024
    Inventors: Lauren OTSUKI, Robert LOVE, Tina FLECK
  • METHOD OF TREATMENT OF DISEASE USING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR
    Publication number: 20090253665
    Abstract: Pharmaceutical compositions comprising an aldosterone inhibitor and an adenosine A1 receptor antagonist (AA1RA) and methods of treating cardiovascular disease comprising identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient are disclosed.
    Type: Application
    Filed: June 16, 2009
    Publication date: October 8, 2009
    Inventors: Lauren Otsuki, Kenneth Widder, Howard C. Dittrich
  • Method of improved diuresis in individuals with impaired renal function
    Patent number: 7579331
    Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
    Type: Grant
    Filed: April 23, 2004
    Date of Patent: August 25, 2009
    Assignee: Novacardia, Inc.
    Inventors: Kenneth J. Widder, Lauren Otsuki, Howard C. Dittrich, Scott Thomson, Roland Blantz
  • METHOD OF TREATMENT OF CARDIAC AND/OR RENAL FAILURE USING A CALCIUM CHANNEL BLOCKER AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR OR AN ANGIOTENSIN II RECEPTOR BLOCKER
    Publication number: 20090118334
    Abstract: A pharmaceutical composition including a calcium channel blocker and an angiotensin II receptor blocker or an angiotensin converting enzyme inhibitor. Also disclosed is a method of treating cardiovascular disease or renal disease by identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient.
    Type: Application
    Filed: January 9, 2009
    Publication date: May 7, 2009
    Applicant: Diakron Pharmaceuticals, Inc.
    Inventors: Howard C. Dittrich, Lauren Otsuki, Kenneth J. Widder
  • Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin II receptor blocker
    Publication number: 20060058355
    Abstract: Disclosed is a pharmaceutical composition comprising a calcium channel blocker and an angiotensin II receptor blocker or an angiotensin converting enzyme inhibitor. Also disclosed is a method of treating cardiovascular disease or renal disease comprising identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient.
    Type: Application
    Filed: August 23, 2005
    Publication date: March 16, 2006
    Inventors: Howard Dittrich, Lauren Otsuki, Kenneth Widder
  • Method of improved diuresis in individuals with impaired renal function
    Publication number: 20060035911
    Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
    Type: Application
    Filed: October 11, 2005
    Publication date: February 16, 2006
    Inventors: Kenneth Widder, Lauren Otsuki, Howard Dittrich, Scott Thomson, Roland Blantz
  • Method of improved diuresis in individuals with impaired renal function
    Publication number: 20060030572
    Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
    Type: Application
    Filed: October 11, 2005
    Publication date: February 9, 2006
    Inventors: Kenneth Widder, Lauren Otsuki, Howard Dittrich, Scott Thomson, Roland Blantz
  • Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor
    Publication number: 20050239759
    Abstract: Pharmaceutical compositions comprising an aldosterone inhibitor and an adenosine A1 receptor antagonist (AA1RA) and methods of treating cardiovascular disease comprising identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient are disclosed.
    Type: Application
    Filed: April 14, 2005
    Publication date: October 27, 2005
    Inventors: Lauren Otsuki, Kenneth Widder, Howard Dittrich
  • Method of improved diuresis in individuals with impaired renal function
    Publication number: 20050004145
    Abstract: Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
    Type: Application
    Filed: April 23, 2004
    Publication date: January 6, 2005
    Inventors: Kenneth Widder, Lauren Otsuki, Howard Dittrich, Scott Thomson, Roland Blantz
  • Method of treatment of disease using an adenosine A1 receptor antagonist
    Publication number: 20040229901
    Abstract: Disclosed are pharmaceutical composition comprising a beta-blocker and an adenosine A1 receptor antagonist (AA1RA), an angiotensin converting enzyme (ACE) inhibitor and an adenosine A1 receptor antagonist (AA1RA), and an angiotensin II receptor blocker (ARB) and an adenosine A1 receptor antagonist (AA1RA). Also disclosed are methods of treating cardiovascular disease, renal disease, alkalosis, or diabetic nephropathy comprising identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient.
    Type: Application
    Filed: February 23, 2004
    Publication date: November 18, 2004
    Inventors: Lauren Otsuki, Howard C. Dittrich, Kenneth J. Widder, Roland Blantz, Scott Thomson